Compile Data Set for Download or QSAR
Report error Found 1404 Enz. Inhib. hit(s) with Target = 'Menin'
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 752288BDBM752288(US20250197392, Compound 51a)
Affinity DataIC50: 0.0240nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200× test compound in DMSO and 4 μL 2× terbium chelate-labeled menin (vide infra for...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 752287BDBM752287(US20250197392, Compound 51)
Affinity DataIC50: 0.0420nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200× test compound in DMSO and 4 μL 2× terbium chelate-labeled menin (vide infra for...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689587BDBM689587(US20240261292, Compound A | US20240261292, Compoun...)
Affinity DataIC50: 0.0900nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689589BDBM689589(US20240261292, Compound A3 | oxalate )
Affinity DataIC50: 0.0980nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689587BDBM689587(US20240261292, Compound A | US20240261292, Compoun...)
Affinity DataIC50: 0.110nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689590BDBM689590(US20240261292, Compound A1 | US12473295, Compound ...)
Affinity DataIC50: 0.180nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793879BDBM793879(US20260055108, Compound 93)
Affinity DataIC50: 0.600nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793943BDBM793943(US20260055108, Compound 110)
Affinity DataIC50: 0.700nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793944BDBM793944(US20260055108, Compound 154)
Affinity DataIC50: 0.800nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793883BDBM793883(US20260055108, Compound 94)
Affinity DataIC50: 0.800nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793961BDBM793961(US20260055108, Compound 26)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793895BDBM793895(US20260055108, Compound 97)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793911BDBM793911(US20260055108, Compound 101)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793931BDBM793931(US20260055108, Compound 106)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793890BDBM793890(US20260055108, Compound 52)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 794018BDBM794018(US20260055108, Compound 84)
Affinity DataIC50: 0.900nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516582BDBM50516582(CHEMBL4449381)
Affinity DataKi: <1nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511905BDBM50511905(CHEMBL4530300)
Affinity DataIC50: 1nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506357BDBM506357(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-((E)-4- (di...)
Affinity DataIC50: 1nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50454121BDBM50454121(CHEMBL4211366)
Affinity DataIC50: 1nMAssay Description:Displacement of FITC-MBM1 from menin (unknown origin) measured after 1 hr by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516569BDBM50516569(CHEMBL4585198 | US10899738, Cpd. No 148)
Affinity DataKi:  1nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793985BDBM793985(US20260055108, Compound 32)
Affinity DataIC50: 1nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793866BDBM793866(US20260055108, Compound 46)
Affinity DataIC50: 1.10nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 794026BDBM794026(US20260055108, Compound 86)
Affinity DataIC50: 1.10nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 794034BDBM794034(US20260055108, Compound 88)
Affinity DataIC50: 1.10nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793946BDBM793946(US20260055108, Compound 66)
Affinity DataIC50: 1.20nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793864BDBM793864(US20260055108, Compound 134)
Affinity DataIC50: 1.30nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50489222BDBM50489222(CHEMBL2314822)
Affinity DataKd:  1.40nMAssay Description:Binding affinity to menin (unknown origin) after 60 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516571BDBM50516571(CHEMBL4592636 | US10899738, Cpd. No 50)
Affinity DataKi:  1.40nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516570BDBM50516570(CHEMBL4551865 | US10899738, Cpd. No 48)
Affinity DataKi:  1.40nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793987BDBM793987(US20260055108, Compound 121)
Affinity DataIC50: 1.5nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793932BDBM793932(US20260055108, Compound 151)
Affinity DataIC50: 1.5nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 794028BDBM794028(US20260055108, Compound 175)
Affinity DataIC50: 1.5nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516567BDBM50516567(CHEMBL4449199 | US10899738, Cpd. No 51)
Affinity DataKi:  1.70nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582737BDBM50582737(CHEMBL5076146)
Affinity DataIC50: 1.70nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793977BDBM793977(US20260055108, Compound 30)
Affinity DataIC50: 1.70nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 794009BDBM794009(US20260055108, Compound 38)
Affinity DataIC50: 1.70nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511899BDBM50511899(CHEMBL4457657 | US11045448, Cpd. No. 67)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793907BDBM793907(US20260055108, Compound 100)
Affinity DataIC50: 1.90nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin [2-610](Human)
Hutchmed

US Patent
LigandChemical structure of BindingDB Monomer ID 793955BDBM793955(US20260055108, Compound 113)
Affinity DataIC50: 1.90nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/9/2026
Entry Details US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516554BDBM50516554(CHEMBL4522767 | US10899738, Cpd. No 49)
Affinity DataKi:  2nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506337BDBM506337(methyl ((1S,2R)-2-((S)-(1-((1-(4-((3- acrylamidoph...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506340BDBM506340(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-acryloylaze...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516568BDBM50516568(CHEMBL4516680)
Affinity DataKi:  2nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506341BDBM506341(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((3- acrylamido...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506342BDBM506342((1S,2R)-2-((S)-(1-((1-(4-((4- acrylamidophenyl)sul...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506346BDBM506346(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-acryloylaze...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511912BDBM50511912(CHEMBL4571451)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511910BDBM50511910(CHEMBL4450979)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511908BDBM50511908(CHEMBL4456003)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 1404 total ) | Next | Last >>
Jump to: